Earnings results for Cleveland BioLabs (NASDAQ:CBLI)
Cytocom Inc. is expected* to report earnings on 08/16/2021 before market open. The report will be for the fiscal Quarter ending Jun 2021. The reported EPS for the same quarter last year was $-0.03.
Analyst Opinion on Cleveland BioLabs (NASDAQ:CBLI)
Dividend Strength: Cleveland BioLabs (NASDAQ:CBLI)
Cleveland BioLabs does not currently pay a dividend. Cleveland BioLabs does not have a long track record of dividend growth.
Insiders buying/selling: Cleveland BioLabs (NASDAQ:CBLI)
In the past three months, Cleveland BioLabs insiders have not sold or bought any company stock. Only 1.03% of the stock of Cleveland BioLabs is held by insiders. Only 6.99% of the stock of Cleveland BioLabs is held by institutions.
Earnings and Valuation of Cleveland BioLabs (NASDAQ:CBLI
Cleveland BioLabs has a P/B Ratio of 22.80. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.
More latest stories: here